Cariprazine as a candidate for drug repurposing in anorexia nervosa: a mechanistic hypothesis grounded in neuroimaging evidence.

In summary, the receptor pharmacology of cariprazine maps with notable specificity onto the neuroimaging-defined substrate of anorexia nervosa, providing a mechanistically grounded rationale for prospective clinical investigation of cariprazine as a candidate pharmacotherapy for this otherwise intractable disorder.